I am happy to disclose the number of Percocet competitors if that would help. Having said that, I agree with the point that price is what matters in the generic market. In order to understand a firm's "pricing power" our folks look at , as a key starting point, the gross margins of that company in comparison to their competitors, It is important to examine ACTUAL gross margins, ie, the actual margins on manufacturing and NOT include non manufacturing revenues in that calculation. SO, I would be interested in your expert analysis of where elite stands in that regard vs competitors. A bit of good news here is that we can discard (from this analysis) the exorbitant amount of CASH paid to Nasrat as I have proven in a previous post .
News 
Market Data 
Discover 
